COMBINATION PHARMACEUTICAL COMPOSITION FOR TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER AND METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER

摘要

The present invention relates to a method of treating attention deficit hyperactivity disorder (ADHD) and attention deficit disorder (ADD) by administration of activated-potentiate form of antibodies to brain-specific protein S-100 and activated-potentiated form of antibodies to endothelial NO synthase, and also to a combination pharmaceutical composition comprising said activated-potentiated forms.